Related Experiment Video
Updated: Feb 7, 2026

Mass Spectrometry Analysis to Identify Ubiquitylation of EYFP-tagged CENP-A EYFP-CENP-A
Published on: June 10, 2020
CENP-E as a target for cancer therapy: Where are we now?
Amr Ahmed El-Arabey1, Salama Abdu Salama1, Adel Rashad Abd-Allah1
1Pharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt.
Abstract:
In 2015, more than 1.6 million new cancer cases with 589,430 deaths were estimated over worldwide. Cancer is a complex disease with abnormal cell growth control which is hallmarked by chromosome misalignment and consequently genomic instability. Mitosis is a well-known target for chemotherapy as taxol and colchicines inhibit tumor cell division by inhibiting mitotic spindle plasticity. Accumulating evidence has revealed that the Centromere-associated Protein E (CENP-E) is expressed during mitosis and plays critical roles in inaccurate chromosome alignment. Thus, CENP-E might represent a druggable target for several solid tumors which do not have targeted therapy. Moreover, CENP-E appears during the mitotic phase of cell cycle and not implicates in the neuronal function. Hence, we will shed light on CENP-E as an emerging target for chemotherapy in clinical oncology and highlight challenges and excitement down the road.
Insights
Centromere-associated Protein E (CENP-E) is crucial for accurate chromosome alignment during mitosis. Targeting CENP-E offers a promising new chemotherapy strategy for solid tumors lacking targeted therapies.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Cancer is a complex disease characterized by uncontrolled cell growth and genomic instability.
- Mitosis is a key target for chemotherapy, with drugs like taxol and colchicine inhibiting cell division by affecting mitotic spindle plasticity.
- Centromere-associated Protein E (CENP-E) is implicated in inaccurate chromosome alignment during mitosis.
Purpose of the Study:
- To explore Centromere-associated Protein E (CENP-E) as a potential therapeutic target in oncology.
- To investigate the role of CENP-E in cancer cell division and its implications for chemotherapy.
- To highlight the challenges and future prospects of CENP-E-targeted therapies.
Main Methods:
- Review of accumulating evidence on CENP-E's role in mitosis.
- Analysis of CENP-E expression patterns during the cell cycle.
- Exploration of CENP-E's druggability for cancer treatment.
Main Results:
- CENP-E is expressed during mitosis and plays a critical role in chromosome alignment.
- Dysregulation of CENP-E can lead to genomic instability.
- CENP-E is not implicated in neuronal function, suggesting a specific therapeutic window.
Conclusions:
- Centromere-associated Protein E (CENP-E) represents a promising druggable target for chemotherapy in solid tumors.
- Targeting CENP-E may offer a novel therapeutic strategy for cancers lacking targeted treatments.
- Further research into CENP-E inhibitors is warranted for clinical oncology applications.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

